Companies
- Companies
- Browse
Companies
Ferndale Laboratories is dedicated to discovering, developing and delivering unique, branded pharmaceuticals that provide therapeutic dermatology solutions to the under-served medical specialties. More
CollaGenex is developing dermatological applications of its proprietary IMPACS™ technology. Oracea™ (doxyxcycline, USP) 40 mg* was approved by the FDA on May 26, 2006. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 160 pages - $1,495
Mar 2011 - 45 pages - $500
Oct 2011 - 75 pages - $500
Jul 2011 - 96 pages - $3,835
Mar 2011 - 38 pages - $250
Mar 2009 - 20 pages - $995
Jul 2007 - 13 pages - $1,295
Mar 2009 - 20 pages - $995
Mar 2011 - 43 pages - $250
Dec 2007 - 49 pages - $495
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Geographic location
- Canada
- USA
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us